UPPER STOMACH GASTRIC IMPLANTS
First Claim
1. A passive intragastric obesity treatment implant, comprising:
- an esophageal stent sized to anchor within the esophagus just above the esophageal sphincter;
a shallow conical ring sized to contact the interior stomach walls adjacent to the esophageal sphincter with a central through hole centered at the esophageal sphincter;
a thin, flexible tether connecting the esophageal stent to the conical ring;
a plurality of thin anchor legs extending from a distal rim of the conical ring, the legs made of a resilient material; and
a shallow cup member attached to the anchor legs opposite from the conical ring and sized to create large spaces between the conical ring and the cup member, the anchor legs having a sufficient length such that the cup member contacts an interior stomach wall opposite the esophageal sphincter,the implant being formed of materials that permit it to be compressed into a substantially linear transoral delivery configuration and that will resist degradation over a period of at least six months within the stomach.
15 Assignments
0 Petitions
Accused Products
Abstract
A variety of passive intragastric implant devices for obesity treatment are disclosed. Such passive devices do not autonomously change shape, but instead react within the stomach to induce satiety. The devices may provide slowed entry into the stomach, thus reducing the intake capacity. Additionally, the devices may contact areas within the stomach, such as the cardia surrounding the esophageal sphincter, to stimulate satiety-inducing nerves. Some devices combine two or more of these satiety-inducing features. Methods of implant are disclosed including compressing the devices within a delivery tube and transorally advancing the devices through the esophagus to be deployed within the stomach. Removal of the devices occurs in the reverse. The implants are formed of materials that permit the implant to be compressed into a substantially linear transoral delivery configuration and that will resist degradation over a period of at least six months within the stomach
41 Citations
20 Claims
-
1. A passive intragastric obesity treatment implant, comprising:
-
an esophageal stent sized to anchor within the esophagus just above the esophageal sphincter; a shallow conical ring sized to contact the interior stomach walls adjacent to the esophageal sphincter with a central through hole centered at the esophageal sphincter; a thin, flexible tether connecting the esophageal stent to the conical ring; a plurality of thin anchor legs extending from a distal rim of the conical ring, the legs made of a resilient material; and a shallow cup member attached to the anchor legs opposite from the conical ring and sized to create large spaces between the conical ring and the cup member, the anchor legs having a sufficient length such that the cup member contacts an interior stomach wall opposite the esophageal sphincter, the implant being formed of materials that permit it to be compressed into a substantially linear transoral delivery configuration and that will resist degradation over a period of at least six months within the stomach. - View Dependent Claims (2, 3)
-
-
4. A passive intragastric obesity treatment implant, comprising:
-
an esophageal stent sized to anchor within the esophagus just above the esophageal sphincter; a cardia-stimulating pillow having perforations and a central opening that aligns with the esophageal sphincter to permit food to pass therethrough; a flexible tether securing cardia-stimulating pillow to the esophageal stent; a balloon-like pillow smaller than the cardia-stimulating pillow having perforations therein; and a thin relatively stiff tube connecting the cardia-stimulating pillow and the balloon-like pillow, the tube having a length sufficient to maintain contact of the cardia-stimulating pillow against the cardia and the balloon-like pillow against the stomach wall opposite the esophageal sphincter, the implant being formed of materials that permit it to be compressed into a substantially linear transoral delivery configuration and that will resist degradation over a period of at least six months within the stomach. - View Dependent Claims (5, 6, 7, 8, 9)
-
-
10. A passive intragastric obesity treatment implant, comprising:
-
an esophageal stent sized to anchor within the esophagus just above the esophageal sphincter; an enlarged cardia-stimulating pillow tethered to the esophageal stent to abut the esophageal opening and being open to the esophagus, the pillow including an artificial stoma opening to the stomach cavity; and a plurality of balloon-like pillows having perforations stacked against the cardia-stimulating pillow so as to reach the interior stomach wall opposite the esophageal sphincter and thus maintain contact of the cardia-stimulating pillow against the cardia; and the implant being formed of materials that permit it to be compressed into a substantially linear transoral delivery configuration and that will resist degradation over a period of at least six months within the stomach. - View Dependent Claims (11, 12, 13, 14, 15)
-
-
16. A passive intragastric obesity treatment implant, comprising:
-
an esophageal mounting stent sized to anchor within the esophagus just above the esophageal sphincter, the stent has a configuration that allows it to change its outer diameter while maintaining an inner diameter aperture substantially constant; and an enlarged cardia-stimulating umbrella tethered to the esophageal stent having a contracted columnar shape for delivery and an expanded splayed out shape that abuts against the cardia surrounding the esophageal sphincter, the implant being formed of materials that permit it to be compressed into a substantially linear transoral delivery configuration and that will resist degradation over a period of at least six months within the stomach. - View Dependent Claims (17, 18, 19, 20)
-
Specification